On Tuesday, Applied Therapeutics Inc (NASDAQ: APLT) was -6.37% drop from the session before settling in for the closing price of $0.41. A 52-week range for APLT has been $0.29 – $10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -19.09%. When this article was written, the company’s average yearly earnings per share was at 23.30%. With a float of $117.55 million, this company’s outstanding shares have now reached $141.58 million.
The extent of productivity of a business whose workforce counts for 35 workers is very important to gauge. In terms of profitability, gross margin is 24.15%, operating margin of -41030.19%, and the pretax margin is -16419.25%.
Applied Therapeutics Inc (APLT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Applied Therapeutics Inc stocks. The insider ownership of Applied Therapeutics Inc is 16.97%, while institutional ownership is 74.93%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 23.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.56% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
You can see what Applied Therapeutics Inc (APLT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 201.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.43, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
The latest stats from [Applied Therapeutics Inc, APLT] show that its last 5-days average volume of 2.43 million was inferior to 3.2 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 11.64%. Additionally, its Average True Range was 0.06.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 12.98%, which indicates a significant increase from 5.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 184.19% in the past 14 days, which was higher than the 115.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4323, while its 200-day Moving Average is $3.4300. Now, the first resistance to watch is $0.4104. This is followed by the second major resistance level at $0.4370. The third major resistance level sits at $0.4522. If the price goes on to break the first support level at $0.3686, it is likely to go to the next support level at $0.3534. Assuming the price breaks the second support level, the third support level stands at $0.3268.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
There are 141,576K outstanding shares of the company, which has a market capitalization of 54.34 million. As of now, sales total 460 K while income totals -105,620 K. Its latest quarter income was 0 K while its last quarter net income were 44,010 K.
